Effect of [6]-Gingerol on viral neuraminidase and hemagglutinin-specific T cell immunity in severe influenza
暂无分享,去创建一个
Tse-Ching Chen | A. Dutta | Sung-Han Hsiao | Ching-Tai Huang | Chun-Yen Lin | Yung-Chang Lin | Chia-Shiang Chang | Chen-Yiu Hung
[1] Hoyoung Lee,et al. Dried Ginger Extract Restores the T Helper Type 1/T Helper Type 2 Balance and Antibody Production in Cyclophosphamide-Induced Immunocompromised Mice after Flu Vaccination , 2022, Nutrients.
[2] Yu-Chia Hsieh,et al. Role of Pneumococcal NanC in the Severe Disease of Streptococcus pneumoniae Superinfection with Influenza , 2021, ImmunoHorizons.
[3] R. T. Sasmono,et al. [6]-Gingerol Inhibits Chikungunya Virus Infection by Suppressing Viral Replication , 2021, BioMed research international.
[4] E. Sadeghi,et al. Effect of ginger (Zingiber officinale) supplementation on oxidative stress parameters: A systematic review and meta-analysis. , 2021, Journal of food biochemistry.
[5] Yu-hua Jia,et al. 6-Gingerol ameliorates sepsis-induced liver injury through the Nrf2 pathway. , 2020, International immunopharmacology.
[6] S. Shih,et al. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[7] H. Corke,et al. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe) , 2019, Foods.
[8] M. T. Islam,et al. Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]‐gingerol in cancer: A comprehensive review , 2018, Phytotherapy research : PTR.
[9] Dayan Wang,et al. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016 , 2017, Antiviral research.
[10] M. Nawaz,et al. Anti-avian influenza virus H9N2 activity of aqueous extracts of Zingiber officinalis (Ginger) and Allium sativum (Garlic) in chick embryos. , 2017, Pakistan journal of pharmaceutical sciences.
[11] Tse-Ching Chen,et al. Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model , 2017, Scientific Reports.
[12] A. Hurt,et al. Influenza antivirals currently in late‐phase clinical trial , 2017, Influenza and other respiratory viruses.
[13] D. Smee,et al. Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice. , 2016, Antiviral research.
[14] H. Kelly,et al. Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin Debate regarding Oseltamivir Use for Seasonal and Pandemic Influenza , 2022 .
[15] Tse-Ching Chen,et al. Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs , 2016, Scientific Reports.
[16] Ha T. Nguyen,et al. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015 , 2014, Antiviral research.
[17] N. Veljkovic,et al. Natural Products as Promising Therapeutics for Treatment of Influenza Disease. , 2015, Current pharmaceutical design.
[18] S. Choi,et al. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza , 2015, Journal of medical virology.
[19] S. Bauer,et al. High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients , 2015, Intensive Care Medicine.
[20] C. Chiu,et al. IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection , 2015, Nature Communications.
[21] Dayan Wang,et al. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014 , 2015, Antiviral research.
[22] J. Liao,et al. Antiviral activity of aloe-emodin against influenza A virus via galectin-3 up-regulation. , 2014, European journal of pharmacology.
[23] D. Smee,et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. , 2013, Antiviral research.
[24] M. Peiris,et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance , 2013, The Lancet.
[25] Tse-Ching Chen,et al. Altered T-bet Dominance in IFN-γ–Decoupled CD4+ T Cells with Attenuated Cytokine Storm and Preserved Memory in Influenza , 2013, The Journal of Immunology.
[26] W. D. Winters,et al. Toxicologic Assessment of a Commercial Decolorized Whole Leaf Aloe Vera Juice, Lily of the Desert Filtered Whole Leaf Juice with Aloesorb , 2013, Journal of toxicology.
[27] Samir Samman,et al. Evaluation of the Nutritional and Metabolic Effects of Aloe vera , 2011 .
[28] Bin Wang,et al. Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia , 2010, Emerging infectious diseases.
[29] M. Eichelberger,et al. Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] R. Saito,et al. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[31] Fang Fang,et al. Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein , 2009, PloS one.
[32] A. Ciucci,et al. Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational Level* , 2009, The Journal of Biological Chemistry.
[33] David Smith,et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. , 2009, Antiviral research.
[34] Alan L Harvey,et al. Natural products in drug discovery. , 2008, Drug discovery today.
[35] H. Ochiai,et al. Macrophage-mediated inhibitory effect of Zingiber officinale Rosc, a traditional oriental herbal medicine, on the growth of influenza A/Aichi/2/68 virus. , 2006, The American journal of Chinese medicine.
[36] U. V. von Andrian,et al. CD4 Effector T Cell Subsets in the Response to Influenza , 2002, The Journal of experimental medicine.
[37] S. Szabo,et al. T-bet regulates IgG class switching and pathogenic autoantibody production , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[38] H. Nagasawa,et al. Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice. , 2002, The American journal of Chinese medicine.
[39] J M Lee,et al. Chemoprotective properties of some pungent ingredients present in red pepper and ginger. , 1998, Mutation research.
[40] P. Doherty,et al. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. , 1997, Journal of immunology.
[41] Takuji Tanaka,et al. Modifying Effects of Fungal and Herb Metabolites on Azoxymethane‐induced Intestinal Carcinogenesis in Rats , 1992, Japanese journal of cancer research : Gann.
[42] R. Sydiskis,et al. Inactivation of enveloped viruses by anthraquinones extracted from plants , 1991, Antimicrobial Agents and Chemotherapy.